Composition Azacitidine (100mg)
Rx Prescription Required
Pack vial of 1 Injection
Storage Store below 30ยฐC
Chemical Class Pyrimidine Nucleoside Analogue
Action Class Antimetabolites
Habbit Forming No
Manufacturer Dr Reddy’s Laboratories Ltd
Manufacturer address Dr. Reddy’s Laboratories Ltd., 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, INDIA

Azacytin Injection
Azacytin Injection is used in the treatment of some kinds of blood cancer. It is used for the treatment of adult patients with all subtypes of Myelodysplastic Syndrome (MDS). It may be also used to treat other conditions, as determined by the doctor.
Basic Info
Description
Azacytin Injection is given as an injection under the medical supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include injection site reactions (pain, swelling, redness), vomiting, weakness, and nausea. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. You must inform your doctor before taking any vaccination while on treatment with this medicine. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Before taking it, tell your doctor if you have liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding.
Uses
Blood cancer
Treatment of Myelodysplastic syndrome
How To Use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
MOA
Azacytin Injection is an anticancer medication. It works by interfering with the growth of genetic material (DNA and RNA) of the cancer cells in leukaemia. This kills the cancer cells and helps in normal maturation and growth of young blood cells in the bone marrow.
What If
Information not available at the moment. Please check back later.
Drug Tips
Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.
Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.
Faqs
Q. Is Azacytin Injection a vesicant?
Azacytin Injection is not a vesicant and is not known to cause severe local tissue damage upon extravasation (leaking of injected Azacytin Injection into the surrounding tissues from the site of administration) when injected
Q. Does Azacytin Injection cause hair loss?
No, Azacytin Injection is not known to cause hair los
Q. Is Azacytin Injection chemotherapy?
Yes. Azacytin Injection is chemotherapy and a cytotoxic drug used in the treatment of various cancers. It is toxic to cancer cells and interferes with the cell’s DNA synthesis, thus slowing down or stopping its growth and multiplication (cytotoxic effect)
Q. Is Azacytin Injection a cytotoxic drug?
Yes. Azacytin Injection is a cytotoxic drug.
Benifits
In Blood cancer
Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body’s ability to fight infection. Azacytin Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
In Treatment of Myelodysplastic syndrome
Azacytin Injection is used to treat myelodysplastic syndrome, a group of conditions in which the bone marrow produces blood cells that are abnormal in structure and function, and does not produce enough healthy blood cells. Azacytin Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.show moreshow less
Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youโre worried about them
Constipation
Diarrhea
Chills
Fever
Bruise
Decreased potassium level in blood
Nausea
Weakness
Vomiting
Injection site reactions (pain, swelling, redness)
Safety Profile
Alcohol:CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Azacytin Injection. Please consult your doctor.
Pregnancy:CONSULT YOUR DOCTOR
Azacytin Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding:UNSAFE
Azacytin Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving:UNSAFE
Azacytin Injection may cause side effects which could affect your ability to drive.Azacytin Injection can cause side effects such as tiredness and this may affect your ability to drive.
Kidney:CAUTION
Azacytin Injection should be used with caution in patients with kidney disease. Dose adjustment of Azacytin Injection may be needed. Please consult your doctor.
Liver:CAUTION
Azacytin Injection should be used with caution in patients with liver disease. Dose adjustment of Azacytin Injection may be needed. Please consult your doctor.Use of Azacytin Injection is not recommended in patients with advanced liver cancer.
Refferences
Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmanโs: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1700.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 112-13.
Azacitidine. Uxbridge, UK: Celgene Ltd.; 2008 . view
Central Drugs Standard Control Organisation . view

